INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 202 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,139,000 | -62.3% | 18,100 | -25.8% | 0.60% | +70.9% |
| Q4 2019 | $3,023,000 | -34.6% | 24,400 | -65.0% | 0.35% | -40.1% |
| Q3 2019 | $4,625,000 | -16.6% | 69,700 | 0.0% | 0.59% | +53.9% |
| Q2 2019 | $5,546,000 | -47.7% | 69,700 | -26.5% | 0.38% | -21.8% |
| Q1 2019 | $10,604,000 | +100.9% | 94,800 | +50.7% | 0.49% | +58.9% |
| Q2 2018 | $5,277,000 | -37.2% | 62,900 | -53.9% | 0.31% | -42.4% |
| Q1 2018 | $8,397,000 | -20.6% | 136,500 | -24.6% | 0.54% | -5.5% |
| Q4 2017 | $10,580,000 | +44.8% | 181,110 | +43.9% | 0.57% | +44.6% |
| Q3 2017 | $7,307,000 | +3430.0% | 125,900 | +4096.7% | 0.39% | +734.0% |
| Q3 2013 | $207,000 | – | 3,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $14,787,000 | 2.73% |
| DeepCurrents Investment Group LLC | 416,800 | $9,620,000 | 0.33% |
| DUALITY ADVISERS, LP | 105,668 | $2,439,000 | 0.21% |
| EULAV Asset Management | 335,000 | $7,732,000 | 0.21% |
| Virtus ETF Advisers LLC | 19,375 | $447,000 | 0.19% |
| Hennion & Walsh Asset Management, Inc. | 135,214 | $3,121,000 | 0.19% |
| PDT Partners, LLC | 110,592 | $2,552,000 | 0.18% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 70,256 | $1,622,000 | 0.16% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $3,896,000 | 0.12% |
| WOODWARD DIVERSIFIED CAPITAL, LLC | 8,939 | $206,000 | 0.12% |